Nauffal, Victor
Achanta, Aditya
Goldhaber, Samuel Z.
Piazza, Gregory http://orcid.org/0000-0003-1407-5276
Funding for this research was provided by:
Janssen Research and Development
Article History
Accepted: 2 December 2020
First Online: 15 January 2021
Compliance with ethical standards
:
: Dr. Piazza has received research grant support from EKOS, a BTG International Group company, Bayer, the Bristol Myers Squibb/Pfizer Alliance, Portola, and Janssen and consulting fees from Amgen, Pfizer, Boston Scientific Corporation, Agile, and Thrombolex. Dr. Goldhaber has received research support from Boehringer Ingelheim, Boston Scientific EKOS Division, BMS/Pfizer, Portola, and Janssen, and the NHLBI. He has received consulting fees from Boehringer Ingelheim, Bayer, and Agile. Dr. Nauffal and Mr. Achanta have no conflicts to disclose.
: Not applicable.
: Not applicable.
: Approved by the Institutional Review Board of Mass General Brigham.
Free to read: This content has been made available to all.